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INFLUENZA & PERTUSIS: PREGNANT & NEWBORN CONCERNS

According to the Advisory Committee on Immunization Practices
(ACIP), it is critical and recommended for pregnant patients to receive
annual influenza (flu) vaccine and Tetanus, diphtheria, pertussis (Tdap)
vaccine every pregnancy, irrespective of prior history. The influenza
immunization of pregnant patients can decrease risk of infection and
accompanying complications. With both flu and Tdap immunizations,
pregnant patients not only can “cocoon” their newborns by preventing
infection spread but can also passively transfer their antibodies to their
infants to cover their window of vulnerability.3,4 Because of the
importance of flu and Tdap vaccines in pregnancy and their established
use safety,6 previous studies have investigated barriers to vaccine
uptake in pregnant populations. Miseducation and fear of harm from
vaccines present major barriers to vaccine uptake,7,8 and race, number of
provider visits, provider vaccine recommendation, and parity may also
be predictors of vaccine uptake.8,9,10

PURPOSE &
RESEARCH QUESTIONS
The purpose of this study was to find ways to improve flu and Tdap
vaccination rates in pregnant patients at the University of Tennessee
Family Medicine Clinic at Memphis (UTFMC-M). The research
questions were the following: At UTFMC-M,
1. What were the age, race, and insurance of the patient sample?
2. What were the flu & Tdap vaccination rates in eligible pregnant
patients?
3. How did the UTFMC-M vaccination rates compare to national
vaccination rates?
4. Were there trends that may indicate barriers to vaccine uptake
(physician encouragement, number of prenatal visits, trimester age
at first prenatal visit, high risk clinic status (HRC), parity, age)?
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Fig. 1: UTFMC-M Vaccination Rates
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Fig. 2a: U.S. vs. UTFMC-M Flu Vaccine Rates
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Fig. 2b: U.S. vs. UTFMC-M Tdap & Both Vaccine Rates
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VACCINATION RECOMMENDATION: PREGNANT PATIENTS

Factors Associated with Influenza & Tdap
Vaccine Uptake in Pregnant Patients at the
UT Family Medicine Clinic

% Vaccinated

Pertussis and influenza are prominent, common infections with more
than 15,000 and 50,000,000 annual U.S. cases respectively.1,2 Compared
to the general population, pregnant patients and newborns are more
susceptible to infection complications. For example, pregnant patients
with influenza have higher risks of ICU admission, pneumonia
progression, and adverse perinatal outcomes.3 Infants under 6 months
are more susceptible to infections due to their incomplete, developing
immune system. In fact, majority of morbidity and mortality attributed
to pertussis infection occurs in infants 3 months or younger.4
Furthermore, the earliest recommended vaccination age for influenza is
6 months; for pertussis, 2 months – leaving a considerable window of
vulnerability.5

Q3 ANSWER: US VS. UTFMC-M VACCINATION RATES

52.1%

Flu vacc., eligible (0-41w, n=465)
Tdap vacc., eligible (≥27w, n=317)
Tdap + Flu vacc., eligible (≥27w, n=317)
Not vaccinated, eligible

U.S. national survey pregnant sample
from 2018-2019 flu season.8 UTFMCM pregnant sample (2019-2020). The
samples compared may not be
equivalent. p=0.05.

Fig. 3a: Relationship Between Vaccination Uptake & Physician Encouragement

U.S. national survey pregnant subgroup who
delivered live births in the 2018-2019 flu season.8
UTFMC-M pregnant subgroup who delivered in
query timeframe (2019-2020). The samples
compared may not be equivalent. p=0.05.

● Physician Encouragement
○ There was a positive relationship between encouragement and
vaccination (Fig. 3).
○ There was a positive relationship between Flu vaccine
encouragement and Tdap vaccination, X2 (3, N = 465) =96.994, p <
0.001; between Tdap encouragement and flu vaccination, X2 (2, N
= 465) =61.9, p < 0.001.
● Number of Prenatal Visits
○ Mean rank no. of visits in those who were vaccinated was higher
than those who were not vaccinated (Fig. 4).
○ The flu-vaccinated group had a median of 8 visits; Tdapvaccinated group, 9 visits; unvaccinated patients, 4 visits (Fig. 4).
● Trimester age at 1st prenatal visit
○ There was a relationship between trimester age at 1st prenatal
visit and Tdap vaccination only (Fig. 5).
○ 56.8% of Tdap-vaccinated patients were in trimester 1 at the first
visit; smaller proportions of vaccinated patients were in later
trimesters (Fig. 5).

There was a positive relationship, X2 (1, N = 465) =131, p < 0.001, between
physician encouragement of the flu vaccine and uptake.

● UTFMC-M vaccine rates were on par with U.S. flu vaccine rates and
higher than U.S. Tdap and Tdap & Flu (“both”) vaccination rates.
● There were statistically significant relationships between vaccine
uptake at UTFMC-M and physician encouragement, number of
prenatal visits, and trimester age at first prenatal visit.
● There were no significant relationships between vaccine uptake and
UTFMC-M HRC admittance for high risk pregnancies, parity, or age.
STUDY LIMITATIONS

Fig. 3b: Relationship Between Vaccination Uptake & Physician Encouragement

There was a positive relationship, X2 (6, N = 465) =476, p < 0.001, between
physician encouragement and Tdap uptake.

● US vs. UTFMC-M rates: The US and UTFMC-M samples were likely
not equivalent: UTFMC-M sample was predominantly black and
Medicaid insured; the national study sample, more diverse.8
Additionally, UTFMC-M rates among patients who delivered could
not directly compare with US rates among patients who delivered
live births. Thus the comparison was only a preliminary exploration
of the data.
● Physician Encouragement: EMR did not state encouragement status.
All vaccinated patients and those who declined, both factors
specifically documented in EMR notes by physician, were assumed
to have received physician encouragement.
● Multiple comparisons (esp. a posteriori) may increase error rates.
However, the current study consisted of a priori comparisons, which
are theoretically acceptable for preliminary data exploration.

Fig. 4b: Comparing Prenatal Visits & Tdap Uptake

Fig. 4a: Comparing Prenatal Visits & Flu Uptake

RECOMMENDATIONS

Q1 ANSWER: UTFMC-M PREGNANT PATIENT PREDOMINANT DEMOGRAPHIC

There was a significant difference (U=17467.5, p< 0.001) in number of
prenatal visits between the vaccinated group (M = 8) and not vaccinated
group (M=4).

There was a significant difference (U=4599.5, p<0.001) in number of
prenatal visits between the vaccinated group (M=9) and not
vaccinated group (M=4).

Q2 ANSWER: UTFMC-M VACCINATION RATES

● Flu (Fig. 1): Among pregnant eligible patients (any gestation age,
n=465), 50.1% were flu-vaccinated.
● Tdap (Fig. 1): Among pregnant eligible patients (≥27 weeks, n=317),
73.8% were Tdap-vaccinated.
● Both (Fig. 1): Among pregnant Tdap & Flu eligible patients (≥27
weeks, n=317), 52.1% were Flu & Tdap-vaccinated.

No significant associations were found between vaccination and HRC
status, Parity, and Age. However, statistically significant relationships
were found among the below variables:

SUMMARY

RESULTS
● Age: 26.6 years (mode).
● Race: 84.3% Black (8.2% White, 3.2% Hispanic, 0.9% Asian, 0.4%
American Indian/Alaskan Native, 0.6% other, 2.4% unlisted).
● Insurance: 88% insured by Tenncare (Medicaid) (9.2% commercial,
1.1% self-pay).

Q4 ANSWER: RELATIONSHIPS BETWEEN VACCINATION & VARIABLES OF INTEREST

DISCUSSION

METHODOLOGY
● A query search of all UTFMC-M patients was performed to identify
any patients who were pregnant from September 1, 2019 -April 24,
2020 (included the 2019-2020 flu season). n= 465.
● Data was extracted from the NextGen Enterprise EMR system.
● Inclusion/exclusion criteria: Flu and Tdap vaccine eligibility based on
ACIP recommendations included Flu shot eligible patients = any
gestation age (0-41 weeks); Tdap eligible patients = ≥27 weeks. ≥2
visits to the UTFMC-M High Risk Clinic (HRC), a clinic that specifies
in high risk pregnant patient care, was noted as positive HRC
admittance status.
● IBM SPSS 26 was used for all statistics.
● Chi-square independence and Mann-Whitney U tests were run to
determine the relationship between vaccination rates and the
variables of interest.
● A 95% CI was approximated by calculating 2 standard errors for the
upper and lower limits to compare clinic vaccination rates to
national vaccination rates.

● Flu (Fig. 2a): The national rate (53.7%)8 was within the UTFMC-M flu
rate 95% confidence interval (50.1%, 95% CI: 45.5-54.7%, p=0.05).
● Tdap (Fig. 2b): The UTFMC-M rate among patients who delivered
(79.9%, 95% CI: 74.4-85.4%, p=0.05) was higher than the national rate
(54.9%, among those who delivered live births).8
● Both (Fig. 2b): The UTFMC-M rate among patients who delivered
(56.0%, 95% CI: 49.1-62.8%, p=0.05) was higher than the national rate
(34.8%, among those who delivered live births).8

Figure 5: Relationship between Trimester at first visit & Tdap Vaccination Status

There was a significant relationship, X2 (6, N = 465) =47.635 ,
p<0.001. 56.8% of patients that received the Tdap vaccine (n=234)
were in Trimester 1 (T1) at the first prenatal visit.

(n=234 Tdap

vaccinated
patients)

The U.S. Department of Health & Human Services goal for influenza
immunization during pregnancy is 80%.11 The Centers for Disease
Control & Prevention recommend that all pregnant patients receive the
Tdap vaccine ideally between 27-36 weeks gestation.12 Based on these
and on our study’s findings we recommend the following:
● Continue to encourage vaccination at every visit.
● Continue booking multiple visits (8 for flu, 9 for Tdap).
● Try to prioritize Tdap vaccination higher on problem list for those
who are late prenatal patients.
● Focus on flu vaccine encouragement and education.
Previous rate improvement measures have focused on addressing the
issues of miseducation, fear of harm to the baby,⁷ and physician vaccine
encouragement9,10 through the following strategies:7,13
1. Provide educational updates to physicians on vaccination during
pregnancy from the Assistant Secretary for Health.
2. Educate patients about vaccine safety and efficacy.9
3. Provide quarterly clinic rate reports to all healthcare staff.
4. Create standing orders for vaccine encouragement by all providers.
5. Train nurses on encouraging vaccination and taking initiative in
helping complete immunization for eligible patients.14

